Drug
14c Cort113176
14c Cort113176: highest development phase Phase 1, developed by Corcept Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Corcept Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C]-CORT113176 NCT04990310 | Phase 1 | Healthy |
Latest
No recent events.
Follow 14c Cort113176 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.